About Anavex (AVXL)
Anavex Life Sciences Corp. is a clinical-stage biopharmaceutical company. The Company is engaged in the development of differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases, including drug candidates to tr... Read more
- USD7.50
- USD7.62
- USD7.31
- USD14.44
- -20.80%
- --
- 841.74k
- 977.78k
- 647M
- 3.51
- 96.10%
Stock News
4 hours ago
Companies like GameStop and Trump Media are buying bitcoin. Here’s how investors should proceed.
MarketWatch
4 hours ago
Why Jim Cramer is frustrated by Friday's lower market — plus, good news for 2 of our bank stocks
CNBC
4 hours ago
Unity upgrade, UiPath earnings, Regeneron drug trial results
Yahoo
7 hours ago
Having a master's degree doesn't make you a better worker, say hiring managers—but you’ll still get paid more
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
